Everett Nixon1, James W Simpkins. 1. Department of Pharmacology and Neuroscience, Institute for Aging and Alzheimer's Disease Research, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
Abstract
PURPOSE: Retinal diseases such as macular degeneration and glaucoma are disorders that target specific retinal neurons that can ultimately lead to vision loss. Under these conditions and pathologies, retinal neurons can die via apoptosis that may be due to increased oxidative stress. The neuroprotective effects of 17β-estradiol (E2) and three synthetic nonfeminizing estrogen analogs (ZYC-26, ZYC-23, and ZYC-3) were investigated to examine their abilities to protect retinal neurons against glutamate toxicity. METHODS: Using an in vitro model of glutamate-induced cell death in 661W cells, a mouse cone photoreceptor cell line, shown to express both estrogen receptors (ERs) via immunoblotting, was pretreated with E2 and its analogs and cell viability were assessed. RESULTS: It was observed that E2 and estrogen analogs, ZYC-26 and ZYC-3, were protective against a 5 mM glutamate insult in 661W cells. The neuroprotective abilities of ZYC-26 and ZYC-3 were autonomous of estrogen receptor-α (ERα) and ERβ demonstrated by their ability to protect in the presence of ICI 182780, a pan-ER antagonist with a high affinity for the estrogen receptor. Treatment with PPT and DPN, ERα- and ERβ-specific agonists, respectively, did not protect the 661W cells from the glutamate insult. Studying the membrane ER (mER) or GPR30 did show that activation of the receptor by G1 protected the retinal neuron from insult, whereas G15, an antagonist of the mER was not able to antagonize the protection previously seen. CONCLUSIONS: These data demonstrate that nonfeminizing estrogens may emerge as useful compounds for neuroprotection of retinal cells.
PURPOSE:Retinal diseases such as macular degeneration and glaucoma are disorders that target specific retinal neurons that can ultimately lead to vision loss. Under these conditions and pathologies, retinal neurons can die via apoptosis that may be due to increased oxidative stress. The neuroprotective effects of 17β-estradiol (E2) and three synthetic nonfeminizing estrogen analogs (ZYC-26, ZYC-23, and ZYC-3) were investigated to examine their abilities to protect retinal neurons against glutamatetoxicity. METHODS: Using an in vitro model of glutamate-induced cell death in 661W cells, a mouse cone photoreceptor cell line, shown to express both estrogen receptors (ERs) via immunoblotting, was pretreated with E2 and its analogs and cell viability were assessed. RESULTS: It was observed that E2 and estrogen analogs, ZYC-26 and ZYC-3, were protective against a 5 mM glutamate insult in 661W cells. The neuroprotective abilities of ZYC-26 and ZYC-3 were autonomous of estrogen receptor-α (ERα) and ERβ demonstrated by their ability to protect in the presence of ICI 182780, a pan-ER antagonist with a high affinity for the estrogen receptor. Treatment with PPT and DPN, ERα- and ERβ-specific agonists, respectively, did not protect the 661W cells from the glutamate insult. Studying the membrane ER (mER) or GPR30 did show that activation of the receptor by G1 protected the retinal neuron from insult, whereas G15, an antagonist of the mER was not able to antagonize the protection previously seen. CONCLUSIONS: These data demonstrate that nonfeminizing estrogens may emerge as useful compounds for neuroprotection of retinal cells.
Authors: Consuelo Borrás; Juan Gambini; M Carmen Gómez-Cabrera; Juan Sastre; Federico V Pallardó; Giovanni E Mann; José Viña Journal: Aging Cell Date: 2005-06 Impact factor: 9.304
Authors: Cristina A Augood; Johannes R Vingerling; Paulus T V M de Jong; Usha Chakravarthy; Johan Seland; Gisele Soubrane; Laura Tomazzoli; Fotis Topouzis; Graham Bentham; Mati Rahu; Jesus Vioque; Ian S Young; Astrid E Fletcher Journal: Arch Ophthalmol Date: 2006-04
Authors: Laszlo Prokai; Katalin Prokai-Tatrai; Pal Perjesi; Alevtina D Zharikova; James W Simpkins Journal: Drug Metab Dispos Date: 2003-06 Impact factor: 3.922
Authors: Glen Y Ozawa; Marcus A Bearse; Wendy W Harrison; Kevin W Bronson-Castain; Marilyn E Schneck; Shirin Barez; Anthony J Adams Journal: Optom Vis Sci Date: 2014-06 Impact factor: 1.973
Authors: Catarina Micaelo-Fernandes; Joseph Bouskila; Roberta M Palmour; Jean-François Bouchard; Maurice Ptito Journal: Cells Date: 2022-09-03 Impact factor: 7.666